LFTD Partners Inc. (LIFD) stock
LIFDOTCPharmaceutical PreparationsFiscal year ends December 31
$0.10+0.00 (0.00%)
Close on Oct 19, 2026Market cap $1.48MP/E –Yield –
LFTD Partners ebitda
EBITDA is earnings before interest, taxes, depreciation and amortization, a rough measure of cash profit from operations.
LFTD Partners's ebitda for the twelve months ending Mar 31, 2026 was -$2.92M. For fiscal 2025 it was $1.47M. The highest annual figure on record is $10.00M in fiscal 2022.
Annual ebitda
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $1.47M | – |
| FY2024 | Dec 31, 2024 | -$252.83K | -108.9% |
| FY2023 | Dec 31, 2023 | $2.84M | -71.7% |
| FY2022 | Dec 31, 2022 | $10.00M | +27.1% |
| FY2021 | Dec 31, 2021 | $7.87M | – |
| FY2020 | Dec 31, 2020 | -$1.50M | – |
| FY2019 | Dec 31, 2019 | -$1.26M | – |
| FY2012 | Dec 31, 2012 | -$1.21M | – |
| FY2011 | Dec 31, 2011 | -$163.22K | – |
Quarterly ebitda
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q1 FY2026 | Mar 31, 2026 | -$4.43M | – |
| Q4 FY2025 | Dec 31, 2025 | $175.12K | -16.1% |
| Q3 FY2025 | Sep 30, 2025 | $1.37M | – |
| Q2 FY2025 | Jun 30, 2025 | -$47.13K | – |
| Q1 FY2025 | Mar 31, 2025 | -$188.75K | -126.7% |
| Q4 FY2024 | Dec 31, 2024 | $208.67K | -91.4% |
| Q3 FY2024 | Sep 30, 2024 | -$82.58K | – |
| Q4 FY2023 | Dec 31, 2023 | -$386.91K | -149.6% |
| Q3 FY2023 | Sep 30, 2023 | $707.87K | +40.7% |
| Q2 FY2023 | Jun 30, 2023 | $2.42M | -45.5% |
| Q1 FY2023 | Mar 31, 2023 | -$27.04K | -100.6% |
| Q4 FY2022 | Dec 31, 2022 | $780.09K | -76.0% |
| Q3 FY2022 | Sep 30, 2022 | $503.06K | -78.4% |
| Q2 FY2022 | Jun 30, 2022 | $4.44M | +180.2% |
| Q1 FY2022 | Mar 31, 2022 | $4.20M | +498.2% |
| Q4 FY2021 | Dec 31, 2021 | $3.25M | +576.1% |
| Q3 FY2021 | Sep 30, 2021 | $2.33M | +1864.7% |
| Q2 FY2021 | Jun 30, 2021 | $1.58M | – |
| Q1 FY2021 | Mar 31, 2021 | $702.28K | – |
| Q4 FY2020 | Dec 31, 2020 | $480.89K | – |
| Q3 FY2020 | Sep 30, 2020 | $118.81K | – |
| Q2 FY2020 | Jun 30, 2020 | -$344.86K | – |
| Q1 FY2020 | Mar 31, 2020 | -$1.76M | – |
| Q4 FY2019 | Dec 31, 2019 | -$160.75K | – |
| Q3 FY2019 | Sep 30, 2019 | -$151.80K | – |
| Q2 FY2019 | Jun 30, 2019 | -$902.44K | – |
| Q1 FY2019 | Mar 31, 2019 | -$47.94K | – |
See a number that looks wrong?